Peptide Library

Not FDA-approved

Bones & muscles

IGF-1 LR3

Evidence

Limited human data

Class

Long-acting IGF-1 variant

/

IGF-1 LR3

KEY TAKEAWAY

IGF-1 LR3 is a modified IGF-1 with a 13-amino-acid extension and a substitution at position 3. It is used mainly in cell culture and is sold online for performance use. IGF-1 LR3 is not FDA-approved. Mecasermin (Increlex) is the approved IGF-1 product.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Long-acting IGF-1 variant

Main uses

Used in cell culture; sold online for muscle growth

Key fact

IGF-1 LR3 is not FDA-approved. Mecasermin (Increlex) is the approved IGF-1 product.

Route

Injected when used outside the lab

Evidence strength

Limited human data

What it is

What it is

IGF-1 LR3 is a modified IGF-1 with a 13-amino-acid extension and a substitution at position 3. It is used mainly in cell culture and is sold online for performance use.

How it works

How it works

The changes reduce binding to IGF-binding proteins, so it stays active longer and is more potent than natural IGF-1.

Regulatory status

Regulatory status

IGF-1 LR3 is not FDA-approved. Mecasermin (Increlex) is the approved IGF-1 product.

What it is used for

What it is used for

Used in cell culture; sold online for muscle growth.

Side effects and risks

Side effects and risks

Low blood sugar and unwanted tissue growth are concerns. Human safety data do not exist.

Citations

Citations

IGF-1 LR3: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo